H26.30
Drug-induced cataract, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
A drug-induced cataract occurs when certain medications cause clouding of the eye's natural lens, leading to vision problems. Identified under the ICD-10 code H26.30, this condition can affect one or both eyes and may develop gradually or more rapidly, depending on the medication and duration of use. Recognizing the link between specific drugs and cataract formation is essential for managing eye health and making informed decisions about medication use.
Causes & Symptoms
Clinical Causes: Long-term use of corticosteroids, such as prednisone or dexamethasone. Use of certain psychotropic drugs, including chlorpromazine and thioridazine. Exposure to radiation therapies involving the eye or surrounding areas. Use of specific medications for glaucoma, like antiglaucoma eye drops with corticosteroids. Other medications, including certain diuretics and antipsychotics, have been linked to cataract formation in some cases.
Key Symptoms: Gradual decline in vision clarity. Blurriness or cloudy appearance in the vision. Difficulty seeing in low light conditions. Sensitivity to glare or halos around lights. Impaired color perception.
Diagnostic & Treatment
Diagnosis Path: Visual acuity tests to assess clarity of vision. Slit-lamp examination to examine the lens and detect cloudiness. Medical history review to identify potential medication-related causes. Fundus examination to evaluate the health of the retina and back of the eye.
Treatment Protocols: Discontinuing or substituting the causative medication under medical supervision when feasible. Corrective lenses or visual aids to improve vision before surgery. Post-operative care to prevent infection and ensure proper healing.
Clinical Advice & FAQs
Billing Guidance
Is H26.30 a billable ICD-10 code?
Yes, H26.30 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H26.30?
Clinical documentation must specify the nature of Drug-induced cataract, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
